What will the ultimate impact of these drugs be
# # # BPC-157 went into human trials in Europe years ago under a code name, PL 14736, run by the Croatian drug maker Pliva
Acetil-L-Carnitina, Acetyl Carnitine, Actyl Carnitine, Acetyl L-Carnitine, Actyl-L-Carnitine, Acetyl-L-Carnitine Arginate Dihydrochloride, Acetyl-L-Carnitine Arginate HCl, Actyl-L-Carnitine Arginate HCl, Acetyl-L-Carnitine HCl, Actyl-L-Carnitine HCl, Acetyl L-Carnitine Hydrochloride, Acetyl Carnitine, Actyl-Carnitine, Acetyl-Levocarnitine, Actyl-Lvocarnitine, ALC, Alcar, Carnitine Acetyl Ester, Dihydrochlorure dActyl-L-Carnitine Arginate, Gamma-Trimethyl-Beta-Acetylbutyrobetaine, L-Acetylcarnitine, L-Actylcarnitine, Levacecarnine, N-Acetyl-Carnitine, N-Actyl-Carnitine, N-Acetyl-L-Carnitine, N-Actyl-L-Carnitine, ST-200, Vitamin B(t) Acetate, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-1-propanaminium inner salt
A 2015 clinical trial involving healthy volunteers was canceled and did not lead to any approved uses, according to a clinical trial database